Dinamika pendapatan YoY sajrone rolas wulan kepungkur: Arrowhead Pharmaceuticals (ARWR)

Logo perusahaan publik Arrowhead Corp (ARWR)

Arrowhead Pharmaceuticals (ARWR) is aggressively competing with industry behemoths for leadership in liver therapy, which is reflected in the volatility of the trailing annual revenue change chart. The current value of the parameter is -45.90. While this trend captures the company's authority in RNA interference, the lack of mass-market commercial products and a reliance on partners fail to create sustainable market momentum.

ARWR - Wutah dodolan YoY sajrone rolas wulan kepungkur Arrowhead Pharmaceuticals ing rentang 11.02.2024 - 18.11.2026

Arrowhead Pharmaceuticals, Inc. (ARWR) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Arrowhead Pharmaceuticals
Produk seri arrowheadpharma.com

Year-over-year sales growth (TTM) measures the revenue scaling rate over the last twelve months, neutralizing seasonal fluctuations and one-time adjustments. For Arrowhead Pharmaceuticals (ARWR), this metric reflects the effectiveness of RNA technology commercialization and the volume of partner payments. By analyzing the annual revenue dynamics via the TTM indicator on the GURU.Markets platform, an investor can discern the actual speed of business expansion. A steady acceleration of this metric confirms the success of clinical trials and the market potential of the drugs.